A Multicenter Prospective Non-Interventional Study Assessing the Management of Canadian Women With Uterine Fibroids
Study Identifier
CMO-CAN-WH-0412
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female
Age
18+ years
Protocol Summary
This study will characterize the treatments and outcomes associated with different uterine fibroid treatments in Canada, to understand patients' preferences and satisfaction with different medical and procedural interventions. The study will also assess the effectiveness of ulipristal acetate (Fibristal®) in controlling bleeding, reducing fibroid volume and symptoms, and improvement in patient's quality of life.
Study Locations
Location
Status
Location
Peter Lougheed Centre/University of Calgary
Calgary, Alberta, Canada, T2E 7W7
Status
Not applicable
Location
Urestky Edmonton Clinic
Edmonton, Alberta, Canada, T5T 1L6
Status
Not applicable
Location
Sanders Vancouver Clinic
Vancouver, British Columbia, Canada, V5Z 4E1
Status
Not applicable
Location
Children's and Women's Health Centre of British Columbia - The University of British Columbia
Vancouver, British Columbia, Canada, V6H 3N1
Status
Not applicable
Location
Southern Health Centre
White Rock, British Columbia, Canada, V4B 5C9
Status
Not applicable
Location
Landau Fredericton Clinic
Fredericton, New Brunswick, Canada, E3B 6H5
Status
Not applicable
Showing {first} - {last} of {total} Results